These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12613180)

  • 1. Physicochemical concepts in drug design.
    van de Waterbeemd H
    EXS; 2003; (93):243-57. PubMed ID: 12613180
    [No Abstract]   [Full Text] [Related]  

  • 2. Estimation of aqueous solubility in drug design.
    Huuskonen J
    Comb Chem High Throughput Screen; 2001 May; 4(3):311-6. PubMed ID: 11375745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examination of the computed molecular properties of compounds selected for clinical development.
    Blake JF
    Biotechniques; 2003 Jun; Suppl():16-20. PubMed ID: 12813900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. When poor solubility becomes an issue: from early stage to proof of concept.
    Stegemann S; Leveiller F; Franchi D; de Jong H; Lindén H
    Eur J Pharm Sci; 2007 Aug; 31(5):249-61. PubMed ID: 17616376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification strategies for combinatorial and parallel chemistry.
    Edwards PJ
    Comb Chem High Throughput Screen; 2003 Feb; 6(1):11-27. PubMed ID: 12570749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving compound quality through in vitro and in silico physicochemical profiling.
    van de Waterbeemd H
    Chem Biodivers; 2009 Nov; 6(11):1760-6. PubMed ID: 19937820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based design of combinatorial libraries.
    van Drie JH; Rohrer DC; Blinn JR; Gao H
    EXS; 2003; (93):203-21. PubMed ID: 12613178
    [No Abstract]   [Full Text] [Related]  

  • 8. Recent advances in physicochemical and ADMET profiling in drug discovery.
    Wang J; Skolnik S
    Chem Biodivers; 2009 Nov; 6(11):1887-99. PubMed ID: 19937823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extremal problems for topological indices in combinatorial chemistry.
    Tichy RF; Wagner S
    J Comput Biol; 2005 Sep; 12(7):1004-13. PubMed ID: 16201918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico design of small molecules.
    Bernardo PH; Tong JC
    Methods Mol Biol; 2012; 800():25-31. PubMed ID: 21964780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico physicochemical parameter predictions.
    Wenlock MC; Barton P
    Mol Pharm; 2013 Apr; 10(4):1224-35. PubMed ID: 23305561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorination Patterning: A Study of Structural Motifs That Impact Physicochemical Properties of Relevance to Drug Discovery.
    Huchet QA; Kuhn B; Wagner B; Kratochwil NA; Fischer H; Kansy M; Zimmerli D; Carreira EM; Müller K
    J Med Chem; 2015 Nov; 58(22):9041-60. PubMed ID: 26523333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digital drug discovery.
    Goldman MA
    Genome Biol; 2005; 6(10):348. PubMed ID: 16207366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combinatorial compound libraries for drug discovery: an ongoing challenge.
    Geysen HM; Schoenen F; Wagner D; Wagner R
    Nat Rev Drug Discov; 2003 Mar; 2(3):222-30. PubMed ID: 12612648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational approaches towards the quantification of molecular diversity and design of compound libraries.
    Matter H
    EXS; 2003; (93):125-56. PubMed ID: 12613175
    [No Abstract]   [Full Text] [Related]  

  • 16. Statistical design and application to combinatorial chemistry.
    Rose S
    Drug Discov Today; 2002 Jan; 7(2):133-8. PubMed ID: 11790624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipophilicity in PK design: methyl, ethyl, futile.
    van de Waterbeemd H; Smith DA; Jones BC
    J Comput Aided Mol Des; 2001 Mar; 15(3):273-86. PubMed ID: 11289080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Actual situation and perspective of novel drug discovery].
    Kato R
    Tanpakushitsu Kakusan Koso; 2000 Apr; 45(6 Suppl):763-75. PubMed ID: 10771632
    [No Abstract]   [Full Text] [Related]  

  • 19. Predicting drug-likeness: why and how?
    Ajay
    Curr Top Med Chem; 2002 Dec; 2(12):1273-86. PubMed ID: 12470280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Rule of Five revisited: applying log D in place of log P in drug-likeness filters.
    Bhal SK; Kassam K; Peirson IG; Pearl GM
    Mol Pharm; 2007; 4(4):556-60. PubMed ID: 17530776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.